Fresh analysis suggests that patients who come off new weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who halt traditional lifestyle programs.
Research printed in a major medical journal demonstrates that while overweight individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month once they quit.
"People purchasing these medications should be cognizant of the risk of quick rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to starting weight in about one and a half years.
Analyzing Treatments
The research, which examined dozens of studies involving over 9,000 of patients, compared the effects of these new drugs with older methods.
Researchers emphasize that individuals who shed pounds through lifestyle changes alone generally experience a slower creep back—around 0.1 kg a month—once they finish.
The Reason for the Quick Rebound
Nutrition scientists propose the mechanism of the jabs explains the heightened regain.
GLP-1 drugs imitate a natural hormone called GLP-1, which controls hunger.
"Artificially providing GLP-1 concentrations far above than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication results in appetite is no longer kept in check, making excessive eating much more probable."
A Chronic Condition?
Medical guidelines advise the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, considering the likelihood of relapse, the treatment might need to be long-term.
This opinion is reinforced by drug manufacturers, who say that the findings "underscore the long-term character of obesity," comparing it to managing conditions like high blood pressure.
User Testimonies
Individuals who have stopped the jabs explain a intense resurgence of appetite.
"It felt as if something activating and you're instantly extremely hungry," said a patient.
This difficulty is compounded if patients have not established lasting dietary or behavioural modifications during therapy.
Widespread Adoption
Figures show that millions of adults in the UK have used these injections in the last 12 months, with interest remaining high.
- Adoption is greater among females compared to males.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
Ultimately, clinicians emphasize that while these medications are potent tools for shedding pounds, they are not a permanent fix and lasting health benefits likely depends on ongoing lifestyle support.
